ProQR Therapeutics N.V. revenue breakdown overview

ProQR Therapeutics N.V. revenue for the last year amounted to 20.12 M USD, the most of which — 20.45 M USD — came from its highest performing source at the moment, RNA Based Therapeutics, the year earlier bringing 7.04 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought ProQR Therapeutics N.V. 20.45 M USD, and the year before that — 7.04 M USD.